+157.2%
MRNA vs RBRK
+51.5%
+105.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | RBRK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -2.5% | +7.9% | +5.6% |
| 7D | -1.1% | -7.5% | +6.4% | -0.4% |
| 30D | +126.1% | -10.4% | +136.5% | +127.3% |
| 3M | +190.0% | +21.3% | +168.8% | +172.3% |
| 6M | +157.2% | +50.6% | +106.6% | +130.7% |
| All | +157.2% | +51.5% | +105.7% | +130.7% |
Cumulative growth
Daily Returns
Daily percentage return beside RBRK.
Daily Out/Under-Performance
Portfolio return minus RBRK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RBRK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded RBRK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling